Current Hematologic Malignancy Reports

Papers
(The H4-Index of Current Hematologic Malignancy Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations86
Financial Toxicity in Patients with Hematologic Malignancies: a Review and Need for Interventions38
Monoclonal Gammopathy-Associated Neuropathy28
Management of Chronic Myeloid Leukemia in Children and Young Adults24
Contemporary Updates in the Prevention and Treatment of Graft-Versus-Host Disease22
Telomere Biology Disorder: A Focus on Gastrointestinal and Hepatic Manifestations18
Mutant Calreticulin in MPN: Mechanistic Insights and Therapeutic Implications17
Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities17
Treatment-Free Remission: the New Goal in CML Therapy14
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer14
Value in Myeloma Care: Myth or Reality14
Challenges in Chronic Myeloid Leukemia Management in South America13
Transplantation and Cellular Therapy for Older Adults—The MSK Approach12
Targeting Apoptosis in ALL12
Acute Lymphoblastic Leukemia and Acute Lymphoblastic Lymphoma: Same Disease Spectrum but Two Distinct Diagnoses12
0.038161993026733